Clinical measures at last visit |
Age at death (years) |
89. 3 (6.51) |
Females (%) |
811 (68.0%) |
Education (years) |
16.2 (3.59) |
Purdue pegboard test (no. of pegs/30 s) |
6.7 (3.37) |
Finger-tapping test (taps/10 s) |
47.2 (14.57) |
Time to cover a distance of 8 feet (seconds) |
6.0 (4.23) |
Number of steps required to cover 8 feet (steps) |
9.0 (3.42) |
360 degree turn time (seconds) |
7.9 (6.33) |
Number of steps to complete a 360° turn (steps) |
12.4 (5.69) |
Leg stand (seconds) |
2.18 (2.77) |
Toe stand (seconds) |
3.03 (3.54) |
Grip strength (kilograms) |
32.4 (18.17) |
Pinch strength (kilograms) |
8.14 (5.00) |
Global motor measure |
0.67 (0.26) |
Global parkinsonism score |
17.3 (11.58) |
Instrumental activities of daily living disability |
1076 (90.3%) |
Activity of daily living disability |
757 (63.5) |
Mobility disability |
1038 (87.1) |
Postmortem Indices |
Postmortem interval (hours) |
8.4 (6.04) |
Nigral neuronal loss (moderate-severe) |
155 (13%) |
Lewy bodies (any) |
316 (27%) |
Pathologic Alzheimer's disease (NIA Reagan) |
766 (64%) |
TDP-43 (present beyond amygdala) |
380 (32%) |
Hippocampal Sclerosis (present) |
113 (9%) |
Macroinfarcts present |
430 (36%) |
Microinfarcts present |
337 (28%) |
Atherosclerosis (moderate-severe) |
405(34%) |
Arteriolosclerosis (moderate-severe) |
397 (33%) |
Cerebral amyloid angiopathy (moderate-severe) |
422 (35%) |